Heptares Co-Founder Resigns as VP and CSO of Parent Company Sosei Post author:Sam Post published:January 18, 2018 Post category:BioPharma Dr. Marshall will leave Sosei at the end of February 2018. Source: BioSpace You Might Also Like Chiltern International Ltd. Releases Medidata Rave Value Accelerators For Capturing, Managing And Reporting Clinical Research Data June 7, 2017 Hebron Technology Co. Signs Framework Agreement To Form JV With Ukrainian Company June 25, 2017 St. Jude Medical Discovers New Cardiac Device Flaws, Issues Patch Update February 7, 2017
Chiltern International Ltd. Releases Medidata Rave Value Accelerators For Capturing, Managing And Reporting Clinical Research Data June 7, 2017
